z-logo
open-access-imgOpen Access
Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia
Author(s) -
Michael P. Whyte,
Cheryl R. Greenberg,
Keiichi Ozono,
Richard J. Riese,
Scott Moseley,
Agustin Melian,
David D. Thompson,
Nicholas Bishop,
Christine Hofmann
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2015-3462
Subject(s) - hypophosphatasia , pediatrics , medicine , alkaline phosphatase , chemistry , biochemistry , enzyme
Hypophosphatasia (HPP) is an inborn error of metabolism that, in its most severe perinatal and infantile forms, results in 50-100% mortality, typically from respiratory complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom